News Posts List

CiDrep Informatics Launches Cloud Services Platform


ATLANTA, Georgia – March 15, 2017. CiDrep Informatics, Inc., today announced the addition of Cloud Services to its portfolio of products and solutions. CiDrep Cloud, is a fully automated ecommerce solutions that allows hospitals, health systems, independent physicians’, dental, behavioral health offices and research organizations to purchase, provision and use HIPAA compliant cloud Software-as-a-Service and Infrastructures-as-a-Service with security and ease.

GCMI Launches New Medtech Accelerator


Collaboration with BD adds significant new asset to medtech development ecosystem in Atlanta and the southeast.

Giant deal for Atlanta-based Merial gets final U.S. government OK


A giant deal involving Atlanta-based animal health company Merial has gotten a final green light from U.S. regulators. In the deal, announced last June, Boehringer Ingelheim has acquired Sanofi’s animal care subsidiary, Merial, valued at $13.53 billion, and Sanofi took over Boehringer Ingelheim’s consumer health care business unit, valued at $7.98 billion, as well as cash compensation of $5.54 billion.

Emory and AKESOgen Partner on Healthy Aging Study


ATLANTA February 28, 2016 – Emory University School of Medicine and AKESOgen announced today their collaboration on the Emory Healthy Aging Study. The largest clinical research study ever conducted in Atlanta, the Emory Healthy Aging Study is a game changing effort to further the scientific understanding of how we age. Aiming to identify predictive markers through cutting edge technologies, the study will enable the prediction of diseases occurring more commonly in later years.

Senate Bill Would Modernize FDA MedTech Inspection Process


WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker after introduction in the U.S. Senate of bipartisan legislation (S. 404) to modernize FDA’s medical device inspections process:

CorMatrix Cardiovascular Secures Fifty-six (56) Patents in 2016 Expanding Patent Protection for Extracellular Matrix (ECM®) Based Implantable Devices


(Roswell, GA –Jan 19, 2017) – CorMatrix® Cardiovascular, Inc., ( a leading developer of biomaterial compositions and medical devices for regenerative medicine, today announced the issuance of 56 patents in 2016. The ongoing expansion of this patent portfolio continues to support the Company’s development of novel extracellular matrix (ECM®) based devices and compositions. Of the fifty-six patents, 19 were obtained internationally. CorMatrix currently holds 13 trademarks related to its Extracellular Matrix products and the Company has secured some 128 patents affording significant intellectual property protection in the area of regenerative medicine. CorMatrix ECM is a naturally occurring bioscaffold that remodels over time into healthy, organized tissue that is site specific.

MAP Announces Partnership with Intent Solutions to Assess Medication Compliance in Patients with ADD


MAP Health Management, LLC., announced today a partnership with Intent Solutions designed to track adherence to medication protocols for patients with a Substance Use Disorder diagnosis who are served by MAP’s patient engagement technology. Intent Solutions is the creator of the TAD™, a biometric pill dispensation device that can track in real-time who has or has not taken their medication.

Lieutenant Governor Casey Cagle Named Georgia Bio Lawmaker of the Year


ATLANTA, GA (January 25, 2017) -- Georgia Bio has announced that Lieutenant Governor Casey Cagle has been selected as the 2017 Lawmaker of the Year for his support of the life sciences industry and university research in Georgia during the 2016 General Assembly.

Marc Pedersen of Paulding County High School Named Biotech Teacher of the Year


ATLANTA, GA (January 24, 2017) – Marc Pedersen, Ed.S. of Paulding County High School in Dallas, GA has been selected as the 2017 Georgia Bio Biotechnology Teacher of the Year.

GeoVax draws a bead on hep B with therapeutic vaccine deal


GeoVax has partnered with Georgia State University to try to pursue an elusive goal—the development of an effective therapeutic vaccine for hepatitis B virus (HBV) infections.

Previous  |  1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  |  Next